Home/Filings/4/0001572426-17-000028
4//SEC Filing

HORN JURGEN 4

Accession 0001572426-17-000028

CIK 0001618561other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 9:32 PM ET

Size

10.5 KB

Accession

0001572426-17-000028

Insider Transaction Report

Form 4
Period: 2017-07-31
HORN JURGEN
Chief Product Development Ofcr
Transactions
  • Disposition to Issuer

    Restricted Share Units

    2017-07-31$6.59/sh47,250$311,6140 total
    Exercise: $0.13Exp: 2021-07-01Ordinary Shares (47,250 underlying)
  • Disposition to Issuer

    Ordinary Shares

    2017-07-31$6.72/sh15,750$105,8400 total
  • Disposition to Issuer

    Option to purchase Ordinary Shares

    2017-07-31$1.62/sh60,000$97,2000 total
    Exercise: $5.10Exp: 2022-08-26Ordinary Shares (60,000 underlying)
Footnotes (3)
  • [F1]Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer (the "Acquisition")
  • [F2]This option to purchase Ordinary Shares, which would have vested as to 12,000 shares on each of 9/30/17, 12/31/17, 3/31/18, 6/30/18, 9/30/18, 12/31/18, 3/31/19 and 6/30/19, was cancelled in the Acquisition in exchange for a cash payment equal to $97,200. This amount represents the difference between such exercise price per share and the $6.72 consideration per share payable in connection with in the Acquisition, multiplied by the number of shares issuable on exercise of the option.
  • [F3]This restricted share unit, which would have vested and become convertible as to 15,750 shares on each of 7/1/18, 7/1/19 and 7/1/20, in each case subject to payment of the nominal value per share of $0.125 to the Issuer within 30 days of vesting, was cancelled in the Acquisition in exchange for a cash payment equal to $311,613.75. This amount represents the difference between such nominal value per share and the $6.72 consideration per share payable in connection with in the Acquisition, multiplied by the number of shares issuable on conversion of the restricted share unit.

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeother

Related Parties

1
  • filerCIK 0001652810

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:32 PM ET
Size
10.5 KB